The End of Trial-and-Error Treatments
New On Demand Healthcare Upside/Down: With guest Nick Glimcher, CEO of Blue Genes. They discuss bringing real-time data and insights to that patient consultation—and the positive downstream impact.
Read MoreBlue Genes